|
| Virulence profiles | ESBLs producing isolates, number (%) | Non-ESBLs producing isolates, number (%) |
|
| Biofilm-haemagglutination-BssS-fimH | 11 (22%) | 12 (24%) |
| Biofilm-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA | 1 (2%) | 1 (2%) |
| Biofilm-haemagglutination-BssS-fimH-iss | 6 (12%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-BssS-fimH | 7 (14%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-BssS-fimH-iss | 14 (28%) | 3 (6%) |
| Biofilm-BssS-fimH | 1 (2%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-lipase-BssS-fimH | 2 (4%) | 0 (0%) |
| Biofilm-serum resistant-haemagglutination-BssS-fimH-iss-iucA | 3 (6%) | 0 (0%) |
| Biofilm-serum resistant-haemagglutination-lipase-α hemolysis-BssS-fimH | 1 (2%) | 0 (0%) |
| Biofilm-serum resistant-haemagglutination-BssS-fimH-iucA | 1 (2%) | 0 (0%) |
| BssS-fimH | 1 (2%) | 0 (0%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA | 1 (2%) | 0 (0%) |
| Biofilm-haemagglutination-gelatinase-BssS-fimH | 1 (2%) | 1 (2%) |
| Hypermucoviscosity-BssS-fimH | 0 (0%) | 2 (4%) |
| Biofilm-haemagglutination-hypermucoviscosity-BssS-fimH | 0 (0%) | 18 (36%) |
| Biofilm-haemagglutination-hypermucoviscosity-α hemolysis-BssS-fimH | 0 (0%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA | 0 (0%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-lipase-α-hemolysis-BssS-fimH-iss | 0 (0%) | 1 (2%) |
| Biofilm-haemagglutination-hypermucoviscosity-gelatinase-BssS-fimH | 0 (0%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss | 0 (0%) | 2 (4%) |
| Biofilm-haemagglutination-hypermucoviscosity-lipase-BssS-fimH-iss-iucA | 0 (0%) | 1 (2%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-lipase-BssS-fimH | 0 (0%) | 2 (4%) |
| Biofilm-serum resistant-haemagglutination-hypermucoviscosity-lipase-BssS-fimH-iss | 0 (0%) | 1 (2%) |
|
| Total | 50 (100%) | 50 (100%) |
|
